We also confirmed that siRNA-mediated PRL-3 knockdown significantly repressed cell proliferation and invasion in line with previous reports for other GC cell lines [25,27], and furthermore for the first time revealed the reduced effect of colony formation under anchorage-independent conditions, supporting that PRL-3 may be attractive therapeutic target against GC. The gene discussed is PTP4A3; the disease is gastric cancer.